Can I Take Vitamin B12 with AndroGel?

Why This Question Comes Up

Men prescribed AndroGel for hypogonadism frequently take vitamin B12 as part of a daily supplement regimen. The question is reasonable: testosterone affects red blood cell production, and B12 is a cofactor in the same process. If both substances stimulate erythropoiesis, could they push hematocrit dangerously high together?

The Short Answer

No direct drug-supplement interaction exists between topical testosterone and vitamin B12. The Natural Medicines Comprehensive Database does not list a clinically significant interaction between these two agents. AndroGel is absorbed through the skin and metabolized hepatically via CYP3A4, while B12 is absorbed in the terminal ileum via intrinsic factor and does not undergo cytochrome P450 metabolism [1].

Where Confusion Originates

The concern typically arises from two overlapping clinical facts. First, testosterone stimulates erythropoietin production in the kidneys, raising red blood cell mass [2]. Second, B12 is required for normal red blood cell maturation. Men sometimes worry the combination could cause polycythemia. The reality is that B12 supplementation in a B12-replete individual does not independently raise hematocrit above reference ranges.

Mechanism Review: How Each Agent Works

Understanding why these two substances don't conflict requires a quick look at their pharmacology.

AndroGel Pharmacokinetics

AndroGel (testosterone gel 1% or 1.62%) delivers testosterone transdermally. After application to the shoulders or upper arms, testosterone diffuses into the dermis, enters systemic circulation, and is metabolized primarily by CYP3A4 in the liver into dihydrotestosterone (DHT) and estradiol [3]. Steady-state serum testosterone is typically achieved within 24 hours of consistent daily dosing. The FDA prescribing information for AndroGel reports mean Cmax values of 600 to 900 ng/dL depending on formulation strength [3].

Vitamin B12 Absorption and Metabolism

Vitamin B12 (cobalamin) binds to intrinsic factor in the stomach and is absorbed via receptor-mediated endocytosis in the terminal ileum. It then binds to transcobalamin II for transport to tissues. B12 acts as a cofactor for two enzymes: methionine synthase (which regenerates methionine from homocysteine) and methylmalonyl-CoA mutase (which converts methylmalonyl-CoA to succinyl-CoA) [4]. Neither enzyme interacts with the androgen receptor or CYP3A4 pathway.

No Shared Metabolic Bottleneck

Because testosterone and B12 use completely different absorption routes, distribution proteins, and metabolic enzymes, there is no pharmacokinetic point of conflict. B12 does not inhibit or induce CYP3A4. Testosterone does not impair intrinsic factor or ileal absorption [5].

The Metformin-B12 Connection in TRT Patients

While AndroGel itself does not affect B12, many men on TRT also take metformin for insulin resistance, metabolic syndrome, or type 2 diabetes. This is where B12 status becomes clinically relevant.

How Metformin Depletes B12

Metformin reduces B12 absorption by interfering with calcium-dependent intrinsic factor-B12 binding in the ileum. A 2010 randomized trial (N=390) published in the BMJ found that metformin 850 mg three times daily decreased serum B12 by 19% over 4.3 years compared to placebo, with 7.2% of metformin-treated patients developing B12 deficiency versus 2.3% on placebo [6]. The American Diabetes Association (ADA) Standards of Care recommend periodic B12 measurement in patients on long-term metformin, particularly those with anemia or peripheral neuropathy [7].

Why This Matters for TRT

Testosterone increases erythropoiesis. If a man on TRT is simultaneously B12-deficient from metformin, his bone marrow receives a strong erythropoietic signal (from testosterone) but lacks a key maturation cofactor (B12). This can produce macrocytic red blood cells that mask the polycythemia signal on a standard CBC.

Put differently: hematocrit might not rise as expected because the red cells being produced are abnormally large and fewer in number. The result can be a falsely reassuring hematocrit alongside worsening B12 deficiency and peripheral neuropathy. Dr. Bradley Anawalt, an endocrinologist at the University of Washington and past president of the Endocrine Society, has noted that "clinicians managing testosterone therapy should screen for nutritional deficiencies that affect erythropoiesis, particularly B12 and iron, to accurately interpret hematologic monitoring" [8].

Erythropoiesis: The Overlapping Concern

Both testosterone and B12 participate in red blood cell production, but at different steps.

Testosterone's Role

Testosterone stimulates renal erythropoietin (EPO) secretion and acts directly on erythroid progenitor cells. The Testosterone Trials (TTrials), a set of seven coordinated placebo-controlled studies (N=788), found that testosterone gel increased hemoglobin by a mean of 1.0 g/dL in men over age 65 [9]. Polycythemia (hematocrit >54%) is the most common lab abnormality requiring TRT dose adjustment, occurring in roughly 5 to 15% of men on transdermal testosterone depending on baseline hematocrit and dose [2].

B12's Role

B12 is required for proper DNA synthesis during erythropoiesis. Without adequate B12, red blood cell precursors undergo megaloblastic changes: they grow larger than normal (macrocytosis) and divide less efficiently. Correcting a B12 deficiency normalizes MCV and restores normal red cell production. It does not cause supraphysiologic erythrocytosis in someone who was already B12-replete [4].

The Clinical Bottom Line

Supplementing B12 in a deficient patient on TRT may transiently raise hematocrit as megaloblastic erythropoiesis corrects itself. This is not a drug interaction. It is the expected physiologic response to restoring a missing nutrient. A man who is B12-replete and begins supplementation will see no meaningful hematocrit change from B12 alone.

Dosing and Timing Recommendations

No dose separation is needed between AndroGel and oral vitamin B12.

AndroGel Application

Apply AndroGel once daily in the morning to clean, dry, intact skin on the shoulders or upper arms. Allow the gel to dry before dressing. Do not shower or swim for at least 2 hours (1% formulation) or 5 hours (1.62% formulation) after application [3].

B12 Supplementation

The typical oral dose for maintenance is 1,000 mcg daily of cyanocobalamin or methylcobalamin. For documented deficiency, the National Institutes of Health Office of Dietary Supplements notes that high-dose oral B12 (1,000 to 2,000 mcg daily) can be as effective as intramuscular injection for most patients [10]. Take B12 at any time of day with or without food. There is no need to separate it from your AndroGel application window.

When Injection Is Preferred

If a patient has pernicious anemia, prior ileal resection, or documented malabsorption, intramuscular B12 (1,000 mcg) is given weekly for 4 weeks, then monthly [10]. This bypasses the intrinsic factor pathway entirely.

Monitoring Protocol for Men on TRT Taking B12

A structured monitoring plan keeps both therapies safe.

Baseline Labs Before Starting TRT

The Endocrine Society Clinical Practice Guideline for Testosterone Therapy recommends checking CBC (including hematocrit), serum testosterone, PSA, and a metabolic panel before initiating TRT [2]. Adding serum B12 and methylmalonic acid (MMA) to the baseline panel is reasonable for any man over 50, on metformin, or with symptoms of neuropathy.

Ongoing Monitoring Schedule

| Lab | Frequency | Action Threshold | |---|---|---| | Hematocrit | 3, 6, 12 months, then annually | >54%: reduce dose or hold TRT | | Serum B12 | Annually (more often if on metformin) | <200 pg/mL: supplement and recheck in 3 months | | Methylmalonic acid | If B12 is borderline (200 to 400 pg/mL) | Elevated MMA confirms tissue-level deficiency | | Homocysteine | Optional | >15 µmol/L may indicate B12 or folate gap | | CBC with differential | 3, 6, 12 months, then annually | Rising MCV with stable hematocrit: suspect B12 depletion |

What Rising MCV Tells You

If a patient on TRT shows a rising mean corpuscular volume (MCV) while hematocrit stays flat or drops, suspect B12 or folate deficiency. Normal TRT-related erythrocytosis produces normocytic cells. Macrocytosis on TRT is not expected and should trigger a B12/folate workup [4].

Populations at Higher Risk for B12 Depletion

Certain subgroups of men on TRT should be screened for B12 deficiency proactively.

Men on Metformin

As discussed above, long-term metformin use (especially at doses of 1,500 mg/day or higher) carries a measurable risk of B12 depletion. A 2016 meta-analysis of 29 studies (N=8,089) published in the Journal of Clinical Endocrinology & Metabolism confirmed that metformin use was associated with a significant reduction in serum B12 (weighted mean difference: -57 pmol/L) and increased risk of B12 deficiency (OR 2.45, 95% CI 1.74 to 3.44) [11].

Men Over 60

Atrophic gastritis affects roughly 10 to 30% of adults over age 60, reducing acid secretion and intrinsic factor production. This impairs B12 absorption from food, though crystalline B12 in supplements remains bioavailable [10].

Men on Proton Pump Inhibitors

Long-term PPI use (omeprazole, pantoprazole, etc.) reduces gastric acid, which is needed to release protein-bound B12 from food. A 2013 case-control study (N=25,956) found that PPI use for 2 or more years was associated with a 65% increased risk of B12 deficiency (OR 1.65, 95% CI 1.58 to 1.73) [12].

Post-Bariatric Surgery Patients

Men who have undergone Roux-en-Y gastric bypass may have reduced intrinsic factor production and shortened ileal exposure time. Lifelong B12 supplementation is standard of care after bariatric surgery per AACE/TOS/ASMBS guidelines [13].

Signs of B12 Deficiency to Watch For

Knowing the symptoms matters because neuropathy from B12 deficiency can be irreversible if caught late.

Neurologic Symptoms

Peripheral neuropathy (tingling, numbness in hands and feet), balance difficulty, and cognitive changes are the hallmark neurologic findings. Subacute combined degeneration of the spinal cord occurs in severe, prolonged deficiency [4].

Hematologic Signs

Macrocytic anemia (elevated MCV, low hemoglobin) is the classic finding, but on TRT, the testosterone-driven erythrocytosis can mask it. A patient might have a "normal" hemoglobin with an abnormally high MCV.

Fatigue Overlap

Both low testosterone and low B12 cause fatigue. If a man reports persistent fatigue despite adequate testosterone levels on TRT, B12 deficiency should be on the differential. Do not assume the fatigue is from an inadequate TRT dose without checking B12.

What to Do If You're Already Taking Both

If you are currently using AndroGel and taking a B12 supplement, there is no reason to stop either one.

Continue applying AndroGel as directed by your prescriber. Continue your B12 supplement at the dose recommended by your clinician or at a standard 1,000 mcg daily maintenance dose. No timing adjustments are needed between the two. At your next TRT follow-up, ask for a serum B12 level if one hasn't been checked in the past 12 months, particularly if you also take metformin or a PPI.

If your B12 level is normal (>400 pg/mL) and you eat a diet that includes animal products, your clinician may determine that supplementation is unnecessary. If your B12 is borderline (200 to 400 pg/mL), a methylmalonic acid level can clarify whether tissue stores are truly low [10].

When to Contact Your Prescriber

Reach out promptly if you develop new numbness or tingling in the hands or feet, unexplained balance problems, or worsening fatigue despite stable testosterone levels. These symptoms warrant a B12 and CBC check. Also contact your prescriber if your hematocrit exceeds 54% on routine bloodwork, as TRT dose adjustment may be needed regardless of B12 status [2].

Men starting metformin while already on TRT should have a baseline B12 drawn before beginning metformin and then annually thereafter per ADA recommendations [7].